ALSA

Dec 13, 2019

ITF Pharma Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIGLUTIK® (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) with a Percutaneous Endoscopic Gastronomy (PEG) Feeding Tube

Feb 28, 2019

ITF Pharma Receives Patient Impact Award for First and Only Easy-To-Swallow Thickened Liquid Treatment for Amyotrophic Lateral Sclerosis (ALS)

Oct 15, 2018

ITF Pharma Announces Availability Of TIGLUTIK(TM) (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) In The United States

Sep 06, 2018

ITF Pharma Announces FDA Approval Of TIGLUTIK(TM) (Riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)

Jul 10, 2018

Alsa Introduces Easy Chrome Paint

May 01, 2018

The ALS Association Calls on Advocates to 'Raise Your Voice' During ALS Awareness Month

Apr 12, 2018

'Project Revoice' Recreates ALS Ice Bucket Challenge Founder's Voice For Him

Mar 28, 2018

Family of Parkland Shooting Victim Who Wanted to Cure ALS Establishes ALS Research Fund

Dec 07, 2017

Balas Begins Role as President and CEO of ALS Association

Dec 07, 2017

Balas Begins Role as President and CEO of ALS Association